-
31.INHIBITORS OF GANGLIOSIDES METABOLISM FOR THE TREATMENT OF MOTOR NEURON DISEASES 审中-公开
Title translation: 神经节苷脂代谢抑制剂治疗运动神经元疾病公开(公告)号:WO2018083223A1
公开(公告)日:2018-05-11
申请号:PCT/EP2017/078156
申请日:2017-11-03
Applicant: ICM (INSTITUT DU CERVEAU ET DE LA MOELLE ÉPINIÈRE) , UNIVERSITÉ PIERRE ET MARIE CURIE - PARIS 6 (UPMC) , CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE , INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE) , APHP (ASSISTANCE PUBLIQUE - HÔPITAUX DE PARIS) , ÉCOLE PRATIQUE DES HAUTES ÉTUDES
Inventor: DARIOS, Frédéric , STEVANIN, Giovanni , MOCHEL, Fanny , BRANCHU, Julien , BOUTRY, Maxime
IPC: A61K45/06 , A61K31/445 , A61P25/10
Abstract: The present invention relates to inhibitors of gangliosides metabolism for treating motor neuron diseases, in particular hereditary spastic paraplegias.
Abstract translation: 本发明涉及用于治疗运动神经元疾病,特别是遗传性痉挛性截瘫的神经节苷脂代谢抑制剂。 p>
-
32.
公开(公告)号:WO2016102602A1
公开(公告)日:2016-06-30
申请号:PCT/EP2015/081050
申请日:2015-12-22
Applicant: ICM (INSTITUT DU CERVEAU ET DE LA MOELLE ÉPINIÈRE) , APHP (ASSISTANCE PUBLIQUE - HÔPITAUX DE PARIS) , CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) , UNIVERSITÉ PIERRE ET MARIE CURIE - PARIS 6 (UPMC) , INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE)
Inventor: LE VAN QUYEN, Michel , CHARPIER, Stéphane , MAHON, Séverine
IPC: A61B5/0476 , A61B5/00 , A61N1/36 , A61N1/04
CPC classification number: A61N1/36025 , A61B5/0476 , A61B5/4088 , A61B5/4812 , A61B5/6803 , A61M21/02 , A61M2230/005 , A61M2230/10 , A61M2230/14 , A61M2230/18 , A61M2230/60 , A61N1/0408
Abstract: The present invention relates to methods and devices to consolidate memory and/or cognitive functions by monitoring brain rhythms and delivering a stimulus at an appropriate stage of sleep cycle.
Abstract translation: 本发明涉及通过在睡眠周期的适当阶段监测脑节律并递送刺激来整合记忆和/或认知功能的方法和装置。
-
公开(公告)号:WO2016050973A1
公开(公告)日:2016-04-07
申请号:PCT/EP2015/072860
申请日:2015-10-02
Applicant: ICM (INSTITUT DU CERVEAU ET DE LA MOELLE ÉPINIÈRE) , APHP (ASSISTANCE PUBLIQUE - HÔPITAUX DE PARIS) , UNIVERSITÉ PIERRE ET MARIE CURIE - PARIS 6 (UPMC) , CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) , INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE)
Inventor: DURR, Alexandra , TEZENAS DU MONTCEL, Sophie
CPC classification number: A61B5/1124 , A61B5/162 , A61B5/4064 , A61B5/7264 , A61B5/7275
Abstract: A nine-hole pegboard test and a click test on the dominant hand are combined to obtain a score for the diagnosis of cerebellar impairment.
Abstract translation: 组合一个九孔栓板测试和优势手的点击测试,以获得小脑损伤诊断的分数。
-
34.DEPOLARIZING AGENTS AND NICOTINIC ACETYLCHOLINE RECEPTOR MODULATORS FOR TREATING DOPAMINERGIC-RELATED DISORDERS 审中-公开
Title translation: 用于治疗多杀伤性相关疾病的非离子化剂和非依赖性乙酰胆碱受体调节剂公开(公告)号:WO2014170343A1
公开(公告)日:2014-10-23
申请号:PCT/EP2014/057661
申请日:2014-04-15
Applicant: ICM (INSTITUT DU CERVEAU ET DE LA MOELLE ÉPINIÈRE) , APHP (ASSISTANCE PUBLIQUE - HÔPITAUX DE PARIS) , CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) , INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE) , UNIVERSITÉ PIERRE ET MARIE CURIE - PARIS 6 (UPMC)
Inventor: MICHEL, Patrick Pierre
IPC: A61K38/00 , A61K31/00 , C07K14/705 , A61K38/17 , A61P25/00
CPC classification number: A61K38/22 , A61K31/439 , A61K45/06 , C07K14/70571 , A61K2300/00
Abstract: The present invention relates to a composition comprising a depolarizing agent acting on a receptor expressed by the dopamine neurons of the substantia nigra, and a modulator of the nicotinic cholinergic pathway, wherein said receptor expressed by the dopamine neurons of the substantia nigra is an orexin receptor, a purinergic receptor or a neurokinin receptor; and to the use thereof for proving neuroprotection to a subject or for treating a disease, disorder or condition related to the dysfunction of the dopamine neurons of the substantia nigra in a subject.
Abstract translation: 本发明涉及一种组合物,其包含作用于由黑质的多巴胺神经元表达的受体的去极化剂和烟碱型胆碱能途径的调节剂,其中所述受黑质多巴胺神经元表达的受体是食欲素受体 ,嘌呤能受体或神经激肽受体; 以及其用于证明对受试者的神经保护作用或用于治疗与受试者中黑质的多巴胺神经元的功能障碍相关的疾病,病症或病症的用途。
-
-
-